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ABSTRACT: 
The mannose-6-phosphate/insulin-like growth factor II (M6P/IGF2) receptor is a transmembrane 
protein known to sequester growth factors from the extracellular matrix. This behavior suggests a 
mechanism of tumor suppression. Structurally, the receptor’s extracellular region is segmented 
into 15 homologous repeats, which are divided further into 5 triplet domains, labelled 1-3, 4-6, 7-
9, 10-12, and 13-15. What is notable about the triplets is their propensity to form dimers with 
triplets on a second M6P/IGF2 receptor. In fact, previous studies indicate that this protein functions 
optimally when dimerized. Thus, the purpose of this experiment is to characterize these domain 
interactions. Using a urea and dithiothreitol (DTT) disruption assay, the 7-9 triplet’s potential to 
dimerize was assessed. Preliminary results indicate that proximity is important for mediating 
interactions. The 7-9 triplet binds strongly to other 7-9 triplets on a separate M6P/IGF2 receptor; 
however, its association with any other triplet is not as strong comparatively. 
 
KEYWORDS: 
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INTRODUCTION: 
Structure and Function of the M6P/IGF2 Receptor: 
The mannose-6-phosphate/insulin-like growth factor II (M6P/IGF2) receptor is a 
ubiquitous transmembrane protein linked to a host of cellular functions in vertebrates. Structurally, 
this approximately 300-kDa receptor features a small C-terminal intracellular tail, a 
transmembrane domain, and a large, N-terminal extracellular region1. This extracellular portion 
can be segmented into 15 homologous repeats, which fold into 5 triplet domains2. These triplets 
are approximately 50-75 kDa in size each, and can be labelled 1-3, 4-6, 7-9, 10-12, and 13-15 
starting from the N-terminus. All repeats share a similar β-barrel architecture3, though their ligand 
binding affinities vary (Figure 1). The 10-12 triplet contains the principal insulin-like growth factor 
II (IGF2) binding site, while the 1-3 and 7-9 triplets contain the binding sites for mannosylated 
proteins (M6P proteins)4. The 4-6 triplet only weakly binds M6P proteins, while the 13-15 triplet 
is known to provide support between the full-length receptor’s extracellular and transmembrane 
domains4. 
In mammals, IGF2 is responsible for the promotion of cell growth—especially in 
developing fetuses2. Over-expression of this hormone is also responsible for the growth and 
division of various types of cancer cells5. From a mechanistic standpoint, IGF2 effects this change 
by downregulating apoptosis and upregulating cell proliferation6. Thankfully, the activity of IGF2 
is regulated in part by the M6P/IGF2 receptor. This role therefore designates the receptor as a 
growth inhibitor/tumor suppressor2. In fact, loss-of-function mutations in the gene that codes for 
the M6P/IGF2 protein have been identified in a number of cancerous states7. The wild-type 
receptor is known to sequester IGF2 from the extracellular matrix and internalize it for 
degradation. The receptor-ligand complex is first targeted to a lysosome, where the IGF2 is 
released and destroyed5. Following this, the M6P/IGF2 receptor is recycled back to the surface of 
the cell once more8. 
This receptor is also known to bind M6P proteins and direct them toward their final 
destination within the cell6. In disease states, this functionality can be severely impaired, which 
leads to insufficient breakdown of ligands within the lysosome9. The ability of the M6P/IGF2 
receptor to bind its two primary ligands is thus imperative to maintaining the health of any given 
cell. 
 
Rationale Behind the Current Experiment: 
It has been noted that the M6P/IGF2 receptor binds ligands best when it is dimerized with 
a second M6P/IGF2 receptor10-13; however, there is limited information as to how this interaction 
is mediated. Therefore, the purpose of this experiment is to characterize the way in which this 
receptor dimerizes. This investigation will be carried out at the level of the triplet domains. In other 
words, which triplets interact preferentially with one another? Such information could be used to 
further elucidate the full-length receptor’s mechanism of tumor suppression. 
Undergraduates who have worked previously in Dr. Kreiling’s laboratory have devised a 
method of expressing each triplet domain in isolation2. Many of these triplets were also tagged 
with molecular markers so that they could be visualized once probed with fluorescent antibodies. 
For instance, each of the five triplets have been marked with a FLAG (F) tag. A separate 7-9 
construct has also been labelled with a MycHis (MH) tag. 
Prior work in Dr. Kreiling’s lab has also shown that the 7-9 triplet in particular has an 
affinity for each of the other triplet domains—including itself. The question stated above can thus 
be reformulated. Which of the triplet pairs form the strongest interactions? Two hypotheses can be 
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made regarding the dimerization of the triplets. One conjecture is that the strongest interactions 
will be between identical triplets (i.e. 7-9 and 7-9), which would imply that structure is the best 
predictor of dimerization. Another view is that the strongest interaction will be between triplets 
with similar functions (i.e. 7-9 and 1-3). The strength of the triplets’ interactions can be gauged 
using a chemical disruption assay. Preliminary work suggests that a combination of urea and 
dithiothreitol (DTT) works best for such a procedure. 
The purpose of this current experiment can thus be narrowed considerably. This work aims 
to quantitatively assess the strength of the dimers formed between the 7-9 triplet and every other 
triplet domain. The motivation behind this exercise is self-evident: characterizing the optimal 
binding of the triplets will be critical to understanding the receptor’s role as a tumor suppressor. 
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Figure 1. Structure of the Extracellular M6P/IGF2 Receptor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A cartoon representation of the extracellular portion of the M6P/IGF2 receptor. The individual 
domains have been labelled 1-15, starting from the N-terminus. Triplet regions have been grouped 
together using a color code. The outline of each domain communicates which ligand it binds. These 
binding affinities depend on the receptor’s ability to dimerize with a second M6P/IGF2 receptor 
on the surface of the same cell. 
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MATERIALS AND METHODS: 
DNA Purification: 
 The genes coding for the 7-9MH triplet and all five of the F-tagged triplets had each been 
inserted into their own pCMV5 plasmid vector. Large-scale samples of this DNA were isolated 
using Qiagen’s Plasmid Maxi Prep Kit. Following isolation, the DNA was reconstituted in de-
ionized water. The concentration of the purified DNA was then assessed by reading the absorbance 
of the aqueous DNA solution at 260 nm using a standard UV-Vis spectrophotometer. 
 
Cell Culture: 
 Human embryonic kidney (HEK) 293 cells were incubated at 37 °C in a 5.0% carbon 
dioxide atmosphere. The cells were cultured with Dulbecco’s Modified Eagle Medium (DMEM), 
which contained 5.0% bovine growth serum (BGS). A 1.5 mL aliquot of cells were passaged to a 
new flask with 18 mL of new HEK 293 Media approximately twice a week. 
 
Cell Transfection: 
 A modified calcium phosphate method was used to transfect the HEK 293 cells. Cells were 
split on the first day of the procedure at a ratio of 1:10 in refrigerated HEK 293 Media. Following 
an overnight incubation at 37 °C and 5.0% CO2, the cells were transfected on the second day. Four 
100 mm plates were prepared for each of the following seven conditions. Five of the conditions 
had 7-9MH co-transfected with a F-tagged DNA construct: 1-3F, 4-6F, 7-9F, 10-12F, or 13-15F. 
The sixth condition had 7-9MH co-transfected with a blank pCMV5 vector. The seventh condition 
had 1-3F co-transfected with 7-9F. These final two pairings served as negative experimental 
controls. 
 Each of the DNA constructs described above were prepared in the following solution: 2025 
µL of cell culture grade water, 297 µL of 2.0 M calcium chloride, and the appropriate volume of 
DNA needed to deliver 10 µg of DNA to each plate. This solution was added to 2250 µL of HBS 
(42 mM HEPES, 274 mM sodium chloride, 10 mM potassium chloride, 1.8 mM sodium phosphate 
dibasic, pH 7.40) with vortexing. This mixture was allowed to precipitate for 10 minutes on ice. A 
1.0 mL aliquot of the appropriate mixture was then added to each plate. Following this, the cells 
were again incubated overnight at 37 °C and 5.0% CO2. On the third day of the procedure, the old 
cell media was aspirated off of the plates and replaced with fresh DMEM (containing no BGS). 
 
Cell Lysis: 
 When the cells were ready to be lysed, the media was aspirated off of each plate. The cells 
were then washed twice with HBS, being careful not to disrupt the cells. A third aliquot of HBS 
was delivered to each plate, after which the cells were scraped off. The cells from each condition 
mentioned above were then combined into a 15 mL tube and centrifuged for 3 minutes at 2000 
rpm. The supernatant was discarded following this spin, leaving only a cell pellet. A 1.0 mL aliquot 
of Lysis Mix (1:100 phenylmethylsulfonyl fluoride, 1:500 protease inhibitor complex, in 
Extraction Buffer (10 mM HEPES, 1.0% Triton X-100, 1.0 mM magnesium chloride, pH 7.4)) 
was added to each cell pellet. The cells were incubated in the Lysis Mix for 1 hour, then centrifuged 
for 7 minutes at 13000 rpm. The supernatants, which contained the desired triplet proteins, were 
stored at -80 °C when not in use. 
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Confirmation of Protein Expression: 
 To confirm that the cells had expressed the triplet proteins, the lysates were separated via 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Sample lysates were 
first dyed with Li-Cor’s 4X Protein Loading Buffer (containing 1:10 β-mercaptoethanol) and 
denatured via heat. Proteins were then separated on two identical SDS-PAGE gels (4-20% 
gradient). A Li-Cor Molecular Weight Marker ran alongside the lysates as a size reference. The 
gels were transferred to nitrocellulose membranes using Bio-Rad’s Trans-Blot Turbo instrument 
(25 V, 2.5 A, 7 minutes). 
 Membranes were rinsed end-over-end with Odyssey Blocking Buffer for 1 hour at room 
temperature. One of the two membranes was then probed with an anti-His antibody (1:1000 in 
Odyssey Blocking Buffer) and the other with anti-FLAG antibody (1:1000 in Odyssey Blocking 
Buffer) overnight at 4 °C. Following this incubation with primary antibody, the membranes were 
washed end-over-end with 1X TBST (0.1% Tween 20, 100 mM Tris-HCl, 0.9% sodium chloride, 
pH 7.4) for 5 minutes, a total of three times each. Each membrane was then probed with Li-Cor’s 
IRDye 680RD goat anti-mouse antibody (1:7000 in Odyssey Blocking Buffer) for 30 minutes. 
This was followed by a second round of rinses with 1X TBST. Protein bands were finally detected 
via near-infrared fluorescence imaging using a Li-Cor Odyssey Fc imaging system set to 700 nm. 
 
Confirmation of Dimerization Between 7-9MH and F-tagged Triplets: 
 A nickel pull down assay was used to confirm that the 7-9 triplet formed dimers with every 
other triplet. A ThermoFisher Scientific Ni-NTA slurry was first vortexed, then 40 µL were added 
to a microfuge tube. The slurry was centrifuged at 800 xg for 2 minutes, and afterward the 
supernatant was discarded. The remaining resin was next equilibrated with 40 µL of Equilibration 
Buffer (20 mM sodium phosphate, 10 mM imidazole, 300 mM sodium chloride, pH 7.4) and again 
centrifuged. After removing the Equilibration Buffer, the following was added to the prepared 
nickel resin: 40 µL of cell lysate, 40 µL of Equilibration Buffer, and 80 µL of de-ionized water. 
The resin was then allowed to rotate end-over-end overnight at 4 °C. 
 After equilibration with the sample lysates, the resin was centrifuged again at 800 xg for 2 
minutes. The supernatant was discarded, and 80 µL of Wash Buffer (20 mM sodium phosphate 
monobasic, 20 mM imidazole, 300 mM sodium chloride, pH 7.4) was added. Following this, the 
resin was centrifuged again as before. This wash procedure was done twice. Bound proteins were 
then eluted from the column by adding 10 µL of Elution Buffer (20 mM sodium phosphate, 250 
mM imidazole, 300 mM sodium chloride, pH 7.4) and centrifuging. The supernatant was then 
transferred to a clean microfuge tube. This elution procedure was done a total of three times to 
yield a final volume of 30 µL. The eluted proteins were then separated via SDS-PAGE and 
visualized via immunoblot as described above. 
  
Dimer Disruption Assays: 
 To assess the strength of the dimerization interactions observed between 7-9 and the other 
triplets, a urea and dithiothreitol (DTT) disruption assay was performed. The nickel pull down 
assay was modified slightly, such that 1.0 mL of an aqueous solution of urea (concentration 
variable) and DTT (5 mM) was added to the resin following equilibration with the lysate. The resin 
was then incubated end-over-end for 1 hour at room temperature. Following the disruption, the 
resin was centrifuged at 800 xg for 2 minutes, and the supernatant was discarded. Next, the resin 
was washed twice with 200 µL of Wash Buffer, similar to above. The bound proteins were then 
eluted as before, separated via SDS-PAGE, and visualized via immunoblot. 
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RESULTS: 
Confirmation of Protein Expression: 
The transfection procedure yielded cell lysates which contained appreciable amounts of 
both 7-9MH and each of the F-tagged triplets (Figure 2). The only combination of proteins unable 
to be obtained was the 7-9MH/13-15F pair, which expressed rather poorly in the HEK 293 cells. 
As expected, the pCMV5 vector (used as a negative control) did not fluoresce after 
treatment with either the anti-His or the anti-FLAG antibodies. As such, it can be concluded that 
these primary antibodies bind only to their intended molecular target—in this case, the H- or the 
F-tag respectively. Proteins lacking one of these specific tags are thus rendered invisible according 
to the method of immunoblotting described above. 
 
Confirmation of Dimerization Between 7-9MH and F-tagged Triplets: 
 For all triplet pairs (excluding 7-9MH/13-15F), the 7-9MH receptor and the F-tagged 
receptor were both present on the immunoblot following purification of the lysates with the Ni-
NTA resin (Figure 3). This is notable because the Ni2+ ion bound to the resin has a high affinity 
for polyhistidine regions, such as those comprising the MH-tag. The resin’s manufacturer mentions 
no specific affinity for the F-tag, nor are there any internal polyhistidine regions in the primary 
sequence of the receptor itself. 
Strangely however, the 1-3F/7-9F pair (intended for use as a negative control) shows up 
on the immunoblot as well. Since the nickel resin has no specific affinity for either of these 
proteins, neither one should appear here. The unexpected presence of 1-3F/7-9F most likely 
indicates that the receptors themselves, or the FLAG-tag, are non-specifically binding to the resin. 
 
Dimer Disruption Assays: 
For each of the triplet pairs expressed prior, a disruption assay was performed. Each unique 
assay was then performed in triplicate to ensure reproducibility of results. The 7-9MH/pCMV5 
pair was again used as a negative control (Figure 4). The blank vector was not expected to dimerize 
with 7-9MH, nor was it expected to fluoresce on the immunoblot. The results seen are consistent 
with both of these expectations. 
The incubation of each 7-9MH/triplet-F pair, while on the resin, with high concentrations 
of urea successfully disrupted the protein-protein interaction only when DTT was added 
additionally (Figures 5-8). These denaturants also had no visible effect on the nickel-histidine 
interaction, as evidenced by consistent band intensity across each 7-9MH panel. That said, as the 
concentration of urea was increased, so too did the intensity of the F-tagged bands diminish. This 
suggests that the triplet dimer was being split apart. The extent of this disruption was variable 
depending on which triplet pair was experimented with. 
Critically, this disruption assay shows that—at a given concentration of urea—some 
triplets associate with 7-9 more strongly than others. This is evidenced by the variable intensity of 
the F-tagged bands as seen across the immunoblots. To quantify how much of the intact dimer 
remained after disruption, the intensity of the F-tagged band was measured relative to the 7-9MH 
band after treatment with 8.0 M urea and 5.0 mM DTT (Table 1). A higher percent dimerization 
thus indicates a stronger interaction between the given pair of triplets. Each disruption assay was 
done in triplicate, so the values presented below represent an average across three trials. 
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      Table 1. Extent of Dimerization After Disruption with 8.0 M Urea and 5.0 mM DTT 
 
Triplet Pair 
 
 
7-9MH/1-3F 
 
7-9MH/4-6F 
 
7-9MH/7-9F 
 
7-9MH/10-12F 
 
Percent Dimerized 
 
17% 
 
 
35% 
 
41% 
 
29% 
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Figure 2. Confirmation of Triplet Protein Expression 
 
A) SDS-PAGE gel (4-20% gradient) transferred to a nitrocellulose membrane and immunoblotted 
with anti-His antibodies to confirm the expression of the 7-9MH triplet in the HEK-293 cell 
lysates. B) SDS-PAGE gel (4-20% gradient) transferred to a nitrocellulose membrane and 
immunoblotted with anti-FLAG antibodies to confirm the expression of the F-tagged triplets in 
the HEK-293 cell lysates. The pCMV5 vector functions as a negative control. Two different 7-
9MH/13-15F lysates were blotted to assess which of two available 13-15F constructs expressed 
more protein. 
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Figure 3. Confirmation of Triplet Protein Dimerization 
A) SDS-PAGE gel (4-20% gradient) transferred to a nitrocellulose membrane and immunoblotted 
with anti-His antibodies to confirm the presence of the 7-9MH triplet. B) SDS-PAGE gel (4-20% 
gradient) transferred to a nitrocellulose membrane and immunoblotted with anti-FLAG antibodies 
to confirm the presence of the F-tagged triplets. Triplet pairs were passed through, then eluted, 
from Ni-NTA chromatography resin before separation on the gel. The Ni2+ on the column has a 
high affinity for the MH-tag—and not the F-tag. Thus, the presence of any F-tagged proteins on 
the gel is indirect evidence of dimerization with the 7-9MH protein. The unexpected presence of 
the 1-3F/7-9F pair complicates this assessment, however.  
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Figure 4. Urea/DTT Disruption Assay, 7-9MH/pCMV5 
A) SDS-PAGE gel (4-20% gradient) transferred to a nitrocellulose membrane and immunoblotted 
with anti-His antibodies to confirm the presence of the 7-9MH triplet. B) SDS-PAGE gel (4-20% 
gradient) transferred to a nitrocellulose membrane and immunoblotted with anti-FLAG antibodies 
to confirm the presence of any F-tagged triplet. Triplet pairs were bound to a Ni-NTA 
chromatography column, then treated with 5.0 mM DTT and a variable concentration of urea. The 
proteins that remained on the column following a subsequent wash were eluted and then separated 
via gel. The pCMV5 vector was used as a negative control; thus, it is predictably absent from both 
immunoblots. 
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Figure 5. Urea/DTT Disruption Assay, 7-9MH/1-3F 
A) SDS-PAGE gel (4-20% gradient) transferred to a nitrocellulose membrane and immunoblotted 
with anti-His antibodies to confirm the presence of the 7-9MH triplet. B) SDS-PAGE gel (4-20% 
gradient) transferred to a nitrocellulose membrane and immunoblotted with anti-FLAG antibodies 
to confirm the presence of the 1-3F triplet. Triplet pairs were bound to a Ni-NTA chromatography 
column, then treated with 5.0 mM DTT and a variable concentration of urea. The proteins that 
remained on the column following a subsequent wash were eluted and then separated via gel. The 
intensity of the F-tagged band at high concentrations of urea is assumed to correlate positively 
with the strength of the dimer. 
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Figure 6. Urea/DTT Disruption Assay, 7-9MH/4-6F 
A) SDS-PAGE gel (4-20% gradient) transferred to a nitrocellulose membrane and immunoblotted 
with anti-His antibodies to confirm the presence of the 7-9MH triplet. B) SDS-PAGE gel (4-20% 
gradient) transferred to a nitrocellulose membrane and immunoblotted with anti-FLAG antibodies 
to confirm the presence of the 4-6F triplet. Triplet pairs were bound to a Ni-NTA chromatography 
column, then treated with 5.0 mM DTT and a variable concentration of urea. The proteins that 
remained on the column following a subsequent wash were eluted and then separated via gel. The 
intensity of the F-tagged band at high concentrations of urea is assumed to correlate positively 
with the strength of the dimer. 
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Figure 7. Urea/DTT Disruption Assay, 7-9MH/7-9F 
A) SDS-PAGE gel (4-20% gradient) transferred to a nitrocellulose membrane and immunoblotted 
with anti-His antibodies to confirm the presence of the 7-9MH triplet. B) SDS-PAGE gel (4-20% 
gradient) transferred to a nitrocellulose membrane and immunoblotted with anti-FLAG antibodies 
to confirm the presence of the 7-9F triplet. Triplet pairs were bound to a Ni-NTA chromatography 
column, then treated with 5.0 mM DTT and a variable concentration of urea. The proteins that 
remained on the column following a subsequent wash were eluted and then separated via gel. The 
intensity of the F-tagged band at high concentrations of urea is assumed to correlate positively 
with the strength of the dimer. 
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Figure 8. Urea/DTT Disruption Assay, 7-9MH/10-12F 
A) SDS-PAGE gel (4-20% gradient) transferred to a nitrocellulose membrane and immunoblotted 
with anti-His antibodies to confirm the presence of the 7-9MH triplet. B) SDS-PAGE gel (4-20% 
gradient) transferred to a nitrocellulose membrane and immunoblotted with anti-FLAG antibodies 
to confirm the presence of the 10-12F triplet. Triplet pairs were bound to a Ni-NTA 
chromatography column, then treated with 5.0 mM DTT and a variable concentration of urea. The 
proteins that remained on the column following a subsequent wash were eluted and then separated 
via gel. The intensity of the F-tagged band at high concentrations of urea is assumed to correlate 
positively with the strength of the dimer. 
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DISCUSSION: 
Non-specific Binding to the Ni-NTA Resin: 
As noted above, the presence of each F-tagged triplet on the immunoblot following Ni-
NTA purification is indirect evidence of dimerization with 7-9MH. The resin has no specific 
affinity for the F-tag. Furthermore, the primary sequences of each triplet receptor contain no 
internal polyhistidine regions14. Therefore, these triplets are likely interacting with 7-9MH itself, 
which does bind to the resin. This would be one explanation for why the triplet-F proteins were 
eluted from the resin alongside 7-9MH. 
This conclusion is complicated somewhat by the unexpected presence of the two F-tagged 
proteins (1-3F and 7-9F) when no 7-9MH was present. Since Ni-NTA has no known affinity for 
either, their presence is most likely the result of non-specific resin binding. Preliminary 
experiments have shown that Myc-tagged triplets bind to the resin in isolation as well, so this 
hypothesis can be corroborated somewhat. At the very least, the F-tag is not the cause of this 
unexpected binding. 
That said, are the triplet-F bands seen in the figures above the result of protein dimerization 
or non-specific binding? A definitive assessment cannot be made with the information available 
at this moment, so the results of this entire experiment are highly contentious. Modifications to the 
existing procedure may be made in the meantime to try and eliminate this non-specific binding 
issue. At present, there is an ongoing effort to block the Ni-NTA resin with a highly purified 
protein sample, such as ovalbumin (OVA), before the cell lysates are added. The purpose of this 
would be to minimize unintentional binding (similar to how one would block a membrane prior to 
immunoblotting). The results of this effort are not conclusive enough to be commented on yet, 
however. A second option worth exploring would be to increase the stringency of the Wash Buffer. 
Increasing the concentration of imidazole in the washes would potentially flush the non-specific 
proteins from the resin. 
 
Insight into the Structure of the M6P/IGF2 Receptor: 
If one assumes that the effects of non-specific binding are negligible however, a host of 
conclusions can be drawn regarding the interaction of 7-9 with the other triplets. First, the relative 
amount of triplet-F protein still bound to 7-9MH following the disruption assay suggests that 7-9 
dimerizes preferentially with certain triplet receptors over others. In particular, 7-9 shows the 
highest affinity for other 7-9 triplets. Interactions grow weaker as 7-9 pairs with triplets further 
away from itself, such as 1-3 and (presumably) 13-15. This pattern would indicate that proximity 
plays a role in dimerization. 
This implies, further, that structure is the best predictor of dimerization strength. If two 
triplets are structurally identical (i.e. 7/9 and 7/9) then they will bind together best. Triplet receptor 
function is not as powerful an indicator. If it were, 7-9 would be expected to have a greater affinity 
for 1-3 since both bind extracellular M6P proteins. The nature of each interaction can be 
commented on as well. The disruption assays only succeeded when DTT (a reducing agent) was 
used. This suggests that a disulfide linkage is potentially holding the triplets together, in addition 
to any other non-covalent interactions that might be occurring. 
 
Directives for Future Research: 
Naturally, there are limitations to each of the conclusions made above. For one, this study 
lacks information regarding the 13-15 triplet. Since this receptor did not express in appreciable 
quantities, one can only conjecture about its potential to dimerize with 7-9MH. Based on the trend 
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seen with the other four triplets, a weak interaction can be predicted; however, there is no data at 
present to support this claim. In addition, it is unknown whether the pattern observed with 7-9MH 
will hold true for the other triplets. Separate experiments would need to be done pairing the four 
remaining MH-triplets with the same F-tagged panel used here. Does proximity/structure influence 
the binding of each triplet pair, or just when 7-9 is examined? Of course, depending on the severity 
of the non-specific binding discussed above, all of these previous conclusions might be invalid 
anyway. 
 Once the entire length of the M6P/IGF2 receptor has been characterized, further 
experiments should strive to investigate how dimerization affects the receptor’s ability to sequester 
ligands from the extracellular matrix. Thus, the work presented here is only a small fraction of a 
larger endeavor. Future experiments with the receptor may reveal something about its mechanism 
of tumor suppression that was previously unknown. This knowledge could then be applied toward 
cancer research at large. 
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